OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pseudoscience and fraudulent products for COVID-19 management
Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 42, pp. 62887-62912
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2150-2150
Open Access | Times Cited: 64

Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47

I trust my immunity more than your vaccines: “Appeal to nature” bias strongly predicts questionable health behaviors in the COVID-19 pandemic
Iris Žeželj, Marija Petrović, Anja Ivanović, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0279122-e0279122
Open Access | Times Cited: 18

Regulatory processes involved in clinical trials and intellectual property rights around vaccine development
Nimeet Desai, Shreya Pande, Amol D. Gholap, et al.
Elsevier eBooks (2024), pp. 279-309
Closed Access | Times Cited: 4

Inhaled non-viral delivery systems for RNA therapeutics
Cheng Huang, Hongjian Li, Xing Duan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access

The Vaccine World of COVID-19: India’s Contribution
Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1943-1943
Open Access | Times Cited: 18

Inhalable Vaccines: Can They Help Control Pandemics?
Vivek P. Chavda, Lalitkumar K. Vora, Vasso Apostolopoulos
Vaccines (2022) Vol. 10, Iss. 8, pp. 1309-1309
Open Access | Times Cited: 15

Myths and facts about vaccination
Rajashri Bezbaruah, Ngurzampuii Sailo, Zonunmawii Zonunmawii, et al.
Elsevier eBooks (2024), pp. 441-454
Closed Access | Times Cited: 2

Digital Pseudo-Identification in the Post-Truth Era: Exploring Logical Fallacies in the Mainstream Media Coverage of the COVID-19 Vaccines
Екатерина Веселиновна Тенева
Social Sciences (2023) Vol. 12, Iss. 8, pp. 457-457
Open Access | Times Cited: 4

Microbes and us: microbiology literacy in Greece
Hera Karayanni, Eleni Motsiou, Vasiliki Sapountzi, et al.
FEMS Microbiology Letters (2024) Vol. 371
Open Access | Times Cited: 1

Official risk communication for COVID-19 and beyond: can we do a better job?
Faina Linkov, Christopher Cummings, David J. Dausey
Environment Systems & Decisions (2024) Vol. 44, Iss. 2, pp. 293-300
Open Access | Times Cited: 1

Caution with Journal Selection: Spam, Copycat Journals, and Predatory Publishing
Jaime A. Teixeira da Silva
BioScientific Review (2024) Vol. 6, Iss. 2, pp. 1-7
Open Access | Times Cited: 1

Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19
Vivek P. Chavda, Lalitkumar K. Vora, Rajeev K. Singla, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 46, pp. 3658-3670
Closed Access | Times Cited: 6

Black Salve (or escharotics). A picture about an unorthodox medical preparation in oncology
Yannick Borkens
Skin Health and Disease (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 2

Scoping review on lessons learnt on the promotion and use of drugs and traditional medicine in Africa during COVID-19
Rujeko Samanthia Chimukuche, Rachel Kawuma, Busisiwe Nkosi, et al.
Global Public Health (2024) Vol. 19, Iss. 1
Open Access

How do we change our approach to COVID with the changing face of disease?
Vasso Apostolopoulos, Jack Feehan, Vivek P. Chavda
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 5, pp. 279-287
Closed Access

Preservice Biology Teachers’ Beliefs About Evidence-Based Medicine and Alternative Medicine
Elvira Schmidt, Albert Zeyer, Kerstin Kremer
Science & Education (2024)
Open Access

What is intelligence, really? The futile search for a Holy Grail
Robert J. Sternberg
Learning and Individual Differences (2024) Vol. 116, pp. 102568-102568
Closed Access

Implications of the health information pollution for society, health professionals, and science
Matheus Lotto, Olívia Santana Jorge, Agnes Fátima Pereira Cruvinel, et al.
Journal of Applied Oral Science (2024) Vol. 32
Open Access

Deciphering the Roots of Pharmacists’ Critical Thinking About Pseudoscientific Claims: Insights from a Cross-Sectional Survey
Tomofumi Watanabe, Makiko Matsumoto, Masami Ukawa, et al.
Pharmacy (2024) Vol. 12, Iss. 6, pp. 165-165
Open Access

Human Microbiome, Virome, and Microbial Therapies Against COVID-19
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 423-455
Closed Access

Page 1 - Next Page

Scroll to top